These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34841266)

  • 1. Government policies and firm performance in the COVID-19 pandemic era: a sectoral analysis.
    Turkson D; Addai NB; Chowdhury F; Mohammed F
    SN Bus Econ; 2021; 1(12):168. PubMed ID: 34841266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiscal Stimulus and Firms' Sales and Capital Expenditure During the Global Financial Crisis.
    Correa-Caro C; Medina L; Poplawski-Ribeiro M; Sutton B
    Comp Econ Stud; 2021; 63(3):489-535. PubMed ID: 34366561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 pandemic and capital markets: the role of government responses.
    Beer C; Maniora J; Pott C
    J Bus Econ; 2023; 93(1-2):11-57. PubMed ID: 38013855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on Japanese firms: mobility and resilience via remote work.
    Kawaguchi D; Kitao S; Nose M
    Int Tax Public Financ; 2022; 29(6):1419-1449. PubMed ID: 36092538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A by-product of big government: the attenuating role of public procurement for the effectiveness of grants-based entrepreneurship policy.
    Grajzl P; Srhoj S; Cepec J; Mörec B
    Small Bus Econ (Dordr); 2023 May; ():1-22. PubMed ID: 38625138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of COVID-19 government support and its consequences for firm liquidity and solvency.
    Lalinsky T; Pál R
    Struct Chang Econ Dyn; 2022 Jun; 61():305-335. PubMed ID: 35317527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Firm Exit during the COVID-19 Pandemic: Evidence from Japan.
    Miyakawa D; Oikawa K; Ueda K
    J Jpn Int Econ; 2021 Mar; 59():101118. PubMed ID: 35702632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of government interventions on the stock market during COVID-19: a case study in Indonesia.
    Sinaga J; Wu T; Chen YW
    SN Bus Econ; 2022; 2(9):136. PubMed ID: 35992741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covid-19 in Central America: Firm resilience and policy responses on employment.
    Calzada Olvera B; Gonzalez-Sauri M; Moya DH; Louvin F
    J Policy Model; 2022; 44(6):1280-1295. PubMed ID: 36439293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zombies, again? The COVID-19 business support programs in Japan.
    Hoshi T; Kawaguchi D; Ueda K
    J Bank Financ; 2023 Feb; 147():106421. PubMed ID: 36568842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of COVID-19 related government response stringency and support policies: Evidence from European firms.
    Janzen B; Radulescu D
    Econ Anal Policy; 2022 Dec; 76():129-145. PubMed ID: 35959486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lockdown, employment adjustment, and financial frictions.
    Lastauskas P
    Small Bus Econ (Dordr); 2022; 58(2):919-942. PubMed ID: 38624870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 pandemic on firms: a survey in Guangdong Province, China.
    Zou P; Huo D; Li M
    Glob Health Res Policy; 2020; 5():41. PubMed ID: 32885048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of government policies for Italian firms during the COVID-19 crisis.
    Fasano F; Javier Sánchez-Vidal F; La Rocca M
    Financ Res Lett; 2022 Dec; 50():103273. PubMed ID: 36035254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of hospitals in COVID-19 era: a case study of an affected country.
    Hamdollahzadeh A; Nabilou B; Yusefzadeh H
    Cost Eff Resour Alloc; 2024 Jun; 22(1):50. PubMed ID: 38863012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Wave of COVID-19 Pandemic in Italy: Data and Evidence.
    Bezzini D; Schiavetti I; Manacorda T; Franzone G; Battaglia MA
    Adv Exp Med Biol; 2021; 1353():91-113. PubMed ID: 35137370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Firms' solidity before an exogenous shock: Covid-19 pandemic in Italy.
    Costa S; Sallusti F; Vicarelli C; Zurlo D
    Econ Anal Policy; 2022 Dec; 76():946-961. PubMed ID: 36277035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.